Header Logo

Connection

Raid Aljumaily to Oxazepines

Back to Details
This is a "connection" page, showing publications Raid Aljumaily has written about Oxazepines.
Raid Aljumaily
Connection Strength
0.184
Oxazepines
  1. Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers. Clin Cancer Res. 2021 01 15; 27(2):447-459.
    View in: PubMed
    Score: 0.184
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.